The National Trial Lawyers
  • Home
    • Contact Us
    • Mission & Goals
    • FAQ
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
  • Calendar of Events
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 4.0 Trial Academy 2019
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Study Links Depakote with Lower IQ

Posted on February 13, 2013 by Andrew Findley


Lawyersandsettlements.com; February 12, 2013

Atlanta, GA: A new study suggests the use of Depakote while pregnant is linked with having children with a lower IQ. Previous studies suggested that Depakote side effects included an increased risk of so-called Depakote birth defects in children exposed to the anti-seizure medication prior to birth.

The most recent study, published online in The Lancet Neurology (1/23/13), studied 311 children whose IQ was assessed at six years of age. Researchers found that the average IQ among children exposed to valproate (the generic name for Depakote) prior to birth was 97, whereas the average IQ of children exposed to other antiepileptic drugs was 105 or higher.

Researchers found that the effect of valproate on IQ was dose dependent, meaning the higher the dose, the greater the effect on the children’s IQ. Children exposed to less than 1000 mg per day had IQ levels similar to children exposed to other antiepileptic drugs. Among the cognitive abilities tested were verbal ability and memory.

“Children exposed to valproate did poorly on measures of verbal and memory abilities compared with those exposed to the other antiepileptic drugs,” researchers wrote. They concluded, “Fetal valproate exposure has dose-dependent associations with reduced cognitive abilities across a range of domains at 6 years of age.”

“These results build on our earlier work to show that valproate usage during pregnancy has a significant negative effect on children’s IQ, which lasts beyond their earliest years,” said Professor Kimford Meador, lead researcher on the study, in a news release (found online at eurekalert.org; 1/22/13). He further noted that because IQ at age six is strongly related to adult IQ, these test results suggest that valproate use during pregnancy could have long-term adverse effects on a child’s IQ.

The same children were reportedly used in a similar study at three years of age, to determine the effects of valproate on their cognitive abilities. The outcome of that study resulted in the US Food and Drug Administration (FDA) issuing a warning that exposure to valproate prior to birth was associated with impaired cognitive functions. At the time, the FDA noted that the long-term effects of valproate on IQ and cognitive development are not known.

Valproate has also been linked to an increased risk of neural tube birth defects.

http://www.lawyersandsettlements.com/articles/depakote/depakote-lawsuit-side-effects-13-18470.html?utm_expid=3607522-0&utm_referrer=http%3A%2F%2Fwww.lawyersandsettlements.com%2F#.URv4WfXRZfw

Posted in Blog

Comments are closed.

Search Legal News

 

 

 

 

Recent Posts

Banner Health in $6M settlement over data breach

Banner Health in $6M settlement over data breach

December 9th, 2019

Banner Health has agreed to pay up to $6 million to victims of a massive data breach the Arizona health system experienced in[Read More...]
How E-Cigarettes Figured in a $42.5MTobacco Verdict

How E-Cigarettes Figured in a $42.5MTobacco Verdict

December 9th, 2019

A Florida jury awarded $42.5 million for a Florida man who blamed tobacco behemoths R.J. Reynolds Tobacco[Read More...]
$34M Recovery in Florida Collision With Brain Injury

$34M Recovery in Florida Collision With Brain Injury

December 9th, 2019

A man recovered more than $34 million for injuries he suffered when a car in which he was riding was broadsided by a pic[Read More...]
Ground Rules for Recovering Mass Tort Attorneys’ Fees

Ground Rules for Recovering Mass Tort Attorneys’ Fees

December 8th, 2019

As of August, the Judicial Panel on Multidistrict Litigation reported nearly 200 pending multidistrict litigations [Read More...]
$14M settlement for 2 teens electrocuted while rescuing dog

$14M settlement for 2 teens electrocuted while rescuing dog

December 8th, 2019

The families of two Northern California teenagers electrocuted while trying to rescue a dog from an irrigation can[Read More...]

 

Read More Legal News »

 

Follow Us!


  • Facebook

  • Twitter

  • LinkedIn

 

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.